Group One Trading
ENTA icon

Group One Trading’s Enanta Pharmaceuticals ENTA Stock Holding History

Group One Trading’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92K Sell
200
-700
-78% -$9.41K ﹤0.01% 6922
2026
Q1 		$11.4K Sell
900
-13,700
-94% -$184K ﹤0.01% 6305
2025
Q4 		$230K Buy
14,600
+10,600
+265% +$135K ﹤0.01% 4253
2025
Q3 		$47.9K Buy
4,000
+1,100
+38% +$8.79K ﹤0.01% 5998
2025
Q2 		$21.9K Buy
2,900
+2,500
+625% +$15K ﹤0.01% 6209
2025
Q1 		$2.21K Buy
+400
New +$2.47K ﹤0.01% 6968
2023
Q1 		– Sell
-2,500
Closed -$116K – 7385
2022
Q4 		$116K Sell
2,500
-2,100
-46% -$95.7K ﹤0.01% 4305
2022
Q3 		$239K Buy
4,600
+1,600
+53% +$93.5K ﹤0.01% 3958
2022
Q2 		$142K Sell
3,000
-3,500
-54% -$190K ﹤0.01% 4643
2022
Q1 		$463K Buy
6,500
+6,300
+3,150% +$410K ﹤0.01% 3900
2021
Q4 		$15K Sell
200
-11,100
-98% -$871K ﹤0.01% 7131
2021
Q3 		$642K Buy
11,300
+6,000
+113% +$297K ﹤0.01% 3909
2021
Q2 		$233K Buy
5,300
+3,200
+152% +$157K ﹤0.01% 5071
2021
Q1 		$104K Buy
+2,100
New +$105K ﹤0.01% 5627
2020
Q3 		– Sell
-100
Closed -$5K – 6195
2020
Q2 		$5K Buy
+100
New +$5.17K ﹤0.01% 5352
2020
Q1 		– Sell
-3,000
Closed -$185K – 5370
2019
Q4 		$185K Buy
+3,000
New +$186K ﹤0.01% 3233
2019
Q1 		– Sell
-1,000
Closed -$71K – 4943
2018
Q4 		$71K Buy
+1,000
New +$76.7K ﹤0.01% 3368
2018
Q2 		– Sell
-8,000
Closed -$647K – 5191
2018
Q1 		$647K Sell
8,000
-6,300
-44% -$485K 0.01% 1844
2017
Q4 		$839K Buy
+14,300
New +$716K 0.01% 1857
2014
Q2 		– Sell
-100
Closed -$4K – 5236
2014
Q1 		$4K Buy
+100
New +$3.63K ﹤0.01% 4860

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Group One Trading's ENTA Position: Q2 2026 in Review

Group One Trading held its Enanta Pharmaceuticals (ENTA) position steady in Q2 2026 at 91 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #7122.

Group One Trading first reported a position in ENTA in Q1 2014 and has held it in 21 quarters since. The position peaked at $208K in Q2 2018. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Group One Trading held 91 shares of Enanta Pharmaceuticals worth $1.33K as of Q2 2026.
  • Group One Trading left its Enanta Pharmaceuticals share count unchanged in Q2 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7122 holding.
  • Group One Trading first reported a position in Enanta Pharmaceuticals in Q1 2014 and has held it in 21 quarters since.
  • Group One Trading's Enanta Pharmaceuticals position peaked at $208K in Q2 2018.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.